Research on hepatitis a vaccines published by scientists at Ben-Gurion University

Scientists discuss in "Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial" new findings in hepatitis a. According to recent research from Beer Sheva, Israel, "The objectives of this trial were to test for noninferiority of a virosomal hepatitis A virus (HAV) vaccine (Epaxal) coadministered with routine childhood vaccines compared with Epaxal given alone and to an alum-adjuvanted HAV vaccine (Havrix Junior) coadministered with routine childhood vaccines. Healthy children 12-to 15-month-old were randomized to receive either a pediatric dose (0.25 mL) of Epaxal coadministered...

Want to see the full article?

• Purchase this article for only $3.00